P32379 (PSA5_YEAST) Saccharomyces cerevisiae (strain ATCC 204508 / S288c) (Baker's yeast)
Proteasome subunit alpha type-5 UniProtKBInterProSTRINGInteractive Modelling
260 aa; Sequence (Fasta) ;
9 identical sequences: Saccharomyces cerevisiae: N1P678, G2WEX9, C8Z9E5, C7GNH7, A6ZUR1, B3LHY7; Saccharomyces pastorianus: A0A6C1DRW4; Saccharomyces boulardii: A0A0L8VPR8; Saccharomyces cerevisiae x Saccharomyces kudriavzevii: H0GGY3
It is possible new templates exist for this target since these models were created.
Available Structures
346 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Yeast 20S proteasome soaked with MA9 fraction E/F |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 61×SO4; 8×MG; 2×A1A9B; | |||
| Proteasome Activator Complex |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P43583; | 100 | ||||
| Yeast 20S proteasome soaked with MA9 fraction EF2 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 58×SO4; 6×A1A9B; 5×MG; | |||
| Proteasomal late precursor complex from pre1-1, state 2 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P36040; P38293; P38624; P40302; P40303; Q05778; | 100 | ||||
| Proteasomal late precursor complex from pre1-1, state 1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P36040; P38293; P38624; P40302; P40303; Q05778; | 100 | ||||
| Structure of Proteasome-Pba1-Pba2 Complex |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P36040; P38624; P40302; P40303; Q05778; | 100 | 16×MG; 2×LDZ; | |||
| Yeast 26S proteasome bound to ubiquitinated substrate (1D* motor state) |
Heteromer P07818; P21242; P21243; P23638; P23639; P33297; P33298; P33299; P40302; P40303; P40327; P53549; Q01939; | 100 | 3×ADP; 3×ATP; | |||
| Yeast 26S proteasome bound to ubiquitinated substrate (4D motor state) |
Heteromer P07818; P0CH08; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P33297; P33298; P33299; P38624; P40302; P40303; P40327; P43588; P53549; Q01939; | 100 | 4×ATP; 2×ADP; | |||
| 26S proteasome, s2 state |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 5×ATP; 6×MG; 1×ADP; | |||
| Cryo-EM structure of 13S proteasome core particle assembly intermediate purified from Pre3-1 protea… |
Heteromer P21242; P21243; P22141; P23638; P23639; P25043; P25451; P36040; P38293; P40302; P40303; Q05778; | 100 | ||||
| Cryo-EM structure of Pre-15S proteasome core particle assembly intermediate purified from Pre3-1 pr… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P36040; P38293; P40302; P40303; Q05778; | 100 | ||||
| Core particle assembly intermediate 1 purified from Saccharomyces cerevisiae |
Heteromer P21242; P21243; P22141; P23638; P23639; P25043; P25451; P38293; P40302; P40303; P43583; | 100.0 | ||||
| Preholo-Proteasome from Pre1-1 Pre4-1 Double Mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P36040; P38293; P38624; P40302; P40303; Q05778; | 100.0 | ||||
| Yeast 26S proteasome bound to ubiquitinated substrate (5T motor state) |
Heteromer P07818; P21242; P21243; P23638; P23639; P33297; P33298; P33299; P40302; P40303; P40327; P53549; Q01939; | 100 | 4×ATP; 2×ADP; | |||
| Proteasomal late precursor complex from pre1-1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P36040; P38293; P38624; P40302; P40303; Q05778; | 100 | ||||
| Preholo-Proteasome from Beta 3 D205 deletion |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P36040; P38293; P38624; P40302; P40303; Q05778; | 100.0 | ||||
| Crystal structure of the 20s proteasome from yeast in complex with the proteasome activator PA26 fr… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; Q9U8G2; | 100 | ||||
| 26S proteasome, s4 state |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 4×ATP; 6×MG; 2×ADP; | |||
| 26S proteasome, s6 state |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 4×ATP; 6×MG; 2×ADP; | |||
| CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST IN COMPLEX WITH THE PROTEASOME ACTIVATOR PA26 FR… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; Q9U8G2; | 100 | 14×MG; | |||
| Structure of the 26S proteasome-Ubp6 complex in the si state (Core Particle and Lid) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P38624; P38764; P38886; P40016; P40302; P40303; P43588; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| 26S proteasome, s1 state |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 5×ATP; 6×MG; 1×ADP; | |||
| 26S proteasome, s3 state |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 2×ADP; 6×MG; 4×ATP; | |||
| 26S proteasome, s5 state |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 5×ATP; 6×MG; 1×ADP; | |||
| 26S proteasome Rpt1-RK -Ubp6-UbVS complex in the si state |
Heteromer O13563; O94742; P0CG47; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P43593; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 5×ATP; 6×MG; 1×ADP; | |||
| Yeast 20S proteasome in complex with Macyranone A |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×7IM; 2×MES; | |||
| Yeast 20S proteasome in complex with Blm-pep activator |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 12×CL; 8×MG; 16×EDO; 7×GOL; | |||
| Yeast 20S proteasome soaked with MA9 crude extract |
Heteromer P21243; P22141; P23638; P23639; P25451; P38624; P40302; P40303; | 100.0 | 7×MG; 3×SO4; | |||
| The resting state of yeast proteasome |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Proteasome 20S Core Particle from Beta 3 D205 deletion |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Deep classification of a large cryo-EM dataset defines the conformational landscape of the 26S prot… |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Deep classification of a large cryo-EM dataset defines the conformational landscape of the 26S prot… |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Deep classification of a large cryo-EM dataset defines the conformational landscape of the 26S prot… |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Structure of the 26S proteasome-Ubp6 complex |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P43593; P53549; P62987; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| CRYSTAL STRUCTURE OF THE 20S PROTEASOME FROM YEAST AT 2.4 ANGSTROMS RESOLUTION |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 20×MG; | |||
| Ligand-induced aziridine-formation at subunit beta5 of the yeast 20S proteasome |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×3K4; | |||
| Crystal structure of epoxomicin:20s proteasome reveals a molecular basis for selectivity of alpha,b… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; | |||
| yCP beta5-M45T mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome at 2.3 A resolution |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome beta2-G45A mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×GWZ; 4×MES; 2×SO4; | |||
| yCP in complex with tripeptidic epoxyketone inhibitor 8 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×MES; 4×38N; | |||
| Ligand-induced Lys33-Thr1 crosslinking at subunit beta5 of the yeast 20S proteasome |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×ABA; | |||
| Yeast 20S proteasome in complex with Ac-LAA-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 4×MES; | |||
| Yeast 20S proteasome in complex with Ac-LAV-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 3×MES; | |||
| Yeast 20S proteasome in complex with Ac-APLL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 6×CL; 2×MES; | |||
| Crystal structure of yeast 20S proteasome in complex with ligand 2a |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138; R57T) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; | |||
| Crystal structure of the yeast 20S proteasome in complex with Salinosporamide derivatives: slow sub… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×GPT; | |||
| Crystal structure of yeast 20S proteasome in complex with enone carmaphycin analogue 6 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×EC6; | |||
| Crystal structure of the yeast 20S proteasome in complex with Salinosporamide derivatives: irrevers… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×SA1; | |||
| Crystal structure of 20S proteasome in complex with hydroxylated salinosporamide |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×HYE; | |||
| Yeast 20S proteasome in complex with the peptidic non-covalent binding inhibitor RTS-V5 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 2×FGY; 2×MES; 2×SO4; | |||
| Yeast 20S proteasome in complex with the alkaloid indolo-phakellin (4) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×3WE; | |||
| yCP in complex with BSc4999 (alpha-Keto Phenylamide) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×3E5; | |||
| yCP in complex with MG132 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 6×ALD; | |||
| Yeast 20S proteasome beta5-T1A beta5-K81R double mutant in complex with Bortezomib, propeptide expr… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 4×CL; 4×BO2; | |||
| yCP in complex with Z-Leu-Leu-Leu-B(OH)2 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CIX; | |||
| Yeast 20S proteasome beta5-D166N mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S proteasome beta5-D166N mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Ligand-induced aziridine-formation at the yeast proteasomal subunit beta5 by sulfonate esters |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×3K4; | |||
| yCP beta5-M45A mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; | |||
| Yeast 20S proteasome beta2-H114D mutant in complex with Ac-PAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 1×CL; | |||
| Yeast 20S proteasome in complex with Ac-LAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 4×MES; | |||
| Yeast 20S proteasome beta5-G48C mutant in complex with alpha-chloroacetamide 5 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; 2×54L; | |||
| Yeast 20S proteasome in complex with Ac-LAF-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; | |||
| Crystal structure of the yeast 20S proteasome in complex with 2b |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×MES; | |||
| Yeast 20S proteasome in complex with N3-APAL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 2×MES; | |||
| Yeast 20S proteasome beta2-G45A mutant in complex with ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×GQK; 4×MES; 2×SO4; | |||
| Yeast 20S proteasome in complex with Ac-LAI-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 3×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with bo… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×BO2; | |||
| Crystal structure of 20s proteasome with novel inhibitor K-7174 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×WPI; | |||
| yCP beta5-A49T-mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 6×BO2; | |||
| Structure of yeast 20S open-gate proteasome with Compound 16 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; 2×L3T; 2×MES; | |||
| Structure of yeast 20S open-gate proteasome with Compound 6 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; 2×LZT; 2×MES; | |||
| Structure of yeast 20S open-gate proteasome with Compound 24 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 9×MG; 2×OEU; 2×MES; | |||
| yCP beta5-A49V mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 4×CL; 6×3BV; 2×MES; | |||
| yCP beta5-A50V mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; | |||
| Yeast 20S proteasome beta5-H(-2)A-T1A-K81R triple mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 4×3BV; 2×MES; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 13 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 4×GQT; | |||
| Yeast 20S proteasome in complex with a beta1 / beta2 specific non-peptidic sulfonamide Ligand |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×4UC; | |||
| Yeast 20S proteasome in complex with 44b |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 4×GWT; 4×MES; | |||
| yCP in complex with Z-Leu-Leu-Leu-ketoaldehyde |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 6×2MK; | |||
| yCP beta5-M45I mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome beta5-D166N mutant in complex with MG132 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 4×CL; 4×ALD; | |||
| yCP beta5-A49S-mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 2×MES; | |||
| Yeast 20S proteasome in complex with 13 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×GQT; | |||
| Yeast 20S proteasome beta5-T1S mutant in complex with Bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×BO2; | |||
| yCP beta5-C63F mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×04C; 4×MES; | |||
| yCP beta5-A50V mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×3BV; 2×MES; | |||
| yCP beta5-C63F mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; | |||
| Yeast 20S proteasome in Complex with Kendomycin |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×2YD; | |||
| Yeast 20S proteasome beta2-T(-2)V mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; | |||
| Yeast 20S proteasome beta5-H(-2)T-T1A double mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 4×3BV; 2×MES; | |||
| Yeast 20S proteasome in complex with epoxyketone inhibitor 13 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 5×MES; 4×A1IFK; | |||
| Yeast 20S proteasome in complex with Ac-PLL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 2×MES; | |||
| Proteasome Inhibition by Fellutamide B |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×HXD; | |||
| Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAY-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome in complex with N3-APnLL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 2×MES; | |||
| Yeast 20S proteasome beta2-H114D mutant in complex with Ac-PAD-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; | |||
| Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 1×CL; | |||
| Yeast 20S proteasome in complex with H-APLL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 2×MES; | |||
| Yeast 20S proteasome in complex with Ac-PAA-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with PR… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 2×39V; 2×MES; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ON… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×04C; 4×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×79P; 2×MES; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×6NV; 1×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with PR… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 2×39V; 1×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 2×39V; | |||
| Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×CL; 4×04C; | |||
| Yeast 20S proteasome in complex with a photoswitchable cepafungin derivative (transCep1) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×VOT; 2×CL; | |||
| Structure of yeast 20S proteasome with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×BO2; | |||
| Crystal structure of the yeast 20S proteasome in complex with syringolin B |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×SY2; | |||
| Yeast 20S Proteasome in complex with Vibralactone |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×1Y9; | |||
| Yeast 20S proteasome in complex with PR-957 (epoxide) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×049; | |||
| Crystal structure of yeast CP in complex with Belactosin C |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×BFO; | |||
| yeast 20S proteasome:glidobactin A-complex |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×GDT; | |||
| Alpha-keto-aldehyde binding mechanism reveals a novel lead structure motif for proteasome inhibition |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×EP9; | |||
| Yeast 20S proteasome in complex with the vinyl sulfone LU102 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×1G1; | |||
| Yeast 20S proteasome beta5-K33A mutant (propeptide expressed in trans) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Structure of yeast 20S open-gate proteasome with Compound 34 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×P3N; 2×MES; | |||
| Yeast 20S proteasome beta5-K33A mutant (propeptide expressed in trans) in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 5×3BV; 4×MES; | |||
| Yeast 20S proteasome beta2-H116D mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 1×MES; | |||
| yCP in complex with Z-Leu-Leu-Leu-ketoamide |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×2LV; | |||
| Yeast 20S proteasome beta2-T1A mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome beta5-T1A mutant in complex with Syringolin A, propeptide expressed in trans |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 2×SRG; | |||
| Yeast 20S proteasome in complex with 20 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×GT5; | |||
| yCP beta5-M45I mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 6×04C; 4×MES; | |||
| yCP beta5-M45T mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S proteasome in complex with 29 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 4×GTW; | |||
| Yeast 20S proteasome in complex with 5 (7- and 6-membered ring) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×GVZ; 2×GW2; 2×MES; | |||
| Yeast 20S proteasome beta5-L(-49S)_D17N double mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S proteasome in complex with Cystargolide B |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×EPW; | |||
| Yeast 20S proteasome in complex with Cystargolide B Derivative 1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×EQE; | |||
| yCP beta5-M45T mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with epoxyketone inhibitor 14 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 4×6N5; 2×MES; | |||
| yCP beta5-M45I mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; | |||
| Yeast 20S proteasome with human beta2c (S171G) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAF-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome beta2-H116N mutant in complex with Ac-LAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 4×MES; | |||
| Yeast 20S proteasome beta2-H114D mutant in complex with Ac-LAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 4×MES; | |||
| Yeast 20S proteasome in complex with PR-VI modulator |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 9×MPD; 38×GOL; 56×MG; | |||
| Yeast 20S proteasome in complex with Ac-PAL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 2×MES; | |||
| Yeast 20S proteasome beta2-H116N mutant in complex with Ac-PAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with Ac-LAL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 4×MES; | |||
| Yeast 20S proteasome beta2-H114D mutant in complex with Ac-LAD-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×MES; 1×CL; 2×K; | |||
| Crystal structure of the yeast 20S proteasome in complex with ligand 2c |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | ||||
| Yeast 20S proteasome in complex with Ac-LLL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 5×CL; 4×MES; | |||
| Yeast 20S proteasome beta2-H116D mutant in complex with Ac-PAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; | |||
| Yeast 20S proteasome beta2-H116D mutant in complex with Ac-LAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×MES; | |||
| Yeast 20S proteasome in complex with N3-A(4,4-F2P)nLL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×MES; 2×CL; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 3×CL; 4×79P; 2×MES; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ca… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 16 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GRW; | |||
| Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 2×6NV; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 39 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GT8; 2×MES; | |||
| Yeast 20S proteasome with human beta2i (1-53) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 2×SO4; | |||
| Yeast 20S proteasome with human beta5i (1-138; R57T)in complex with PR-924 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×39V; 2×MES; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×CL; 4×04C; 4×MES; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with PR… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×CL; 4×MES; 2×39V; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with bo… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 4×MES; 2×6NV; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with th… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 2×7DX; | |||
| Yeast 20S proteasome in complex with epoxyketone inhibitor 42 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 9×MG; 5×CL; 3×MES; 4×A1IFL; 3×SO4; | |||
| Yeast 20S proteasome with human beta1i (1-51) in complex with epoxyketone inhibitor LU-001i |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28065; P30656; P30657; P38624; P40302; P40303; | 100.0 | 4×CL; 8×MG; 4×A1IF8; 4×MES; 1×SO4; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with epoxyketone inhibitor 42 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 3×CL; 4×MES; 4×A1IFL; 4×SO4; | |||
| Structure of yeast 20S open-gate proteasome with Compound 8 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; 2×L2T; 2×MES; | |||
| Crystal structure of yeast 20S proteasome in complex with epoxyketone carmaphycin analogue 3 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×OV2; | |||
| Crystal structure of yeast 20S proteasome in complex with vinylketone carmaphycin analogue VNK1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×ONK; 4×VNK; | |||
| Yeast 20S proteasome in complex with the belactosin derivative 3e |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×1KR; | |||
| Crystal structure of yeast 20S proteasome in complex with spirolactacystin |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×SLA; | |||
| Crystal structure of yeast 20S proteasome in complex with the natural product carmaphycin A |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×OV1; | |||
| Crystal structure of Salinosporamide A in complex with the yeast 20S proteasome |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×SA1; | |||
| Crystal structure of the yeast 20S proteasome in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×BO2; | |||
| Proteasome in complex with hydroxyurea derivative HU10 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×MES; 2×H10; | |||
| yCP beta5-A49V mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 6×04C; 2×MES; | |||
| Yeast 20S proteasome beta5-L(-49)S-K33A mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 4×3BV; 2×MES; | |||
| Yeast 20S proteasome in complex with octreotide-PI |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×5BY; | |||
| Yeast 20S proteasome beta5-G48C mutant in complex with ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×MES; 6×04C; 2×NA; | |||
| Structure of yeast 20S proteasome in complex with the natural product beta-lactone inhibitor Cystar… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 6×VSZ; | |||
| Yeast 20S proteasome beta5-G48C mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 1×CL; | |||
| yCP in complex with tripeptidic epoxyketone inhibitor 2 (PR924) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×MES; 2×39V; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 10×MG; 2×CL; 6×GQK; 4×MES; 2×SO4; | |||
| Yeast 20S proteasome beta2-H116E mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×MES; | |||
| Yeast 20S proteasome in complex with alkyne-PI |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 5×CL; 6×5BZ; | |||
| yCP in complex with tripeptidic epoxyketone inhibitor 11 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×MES; 2×37Y; | |||
| yCP in complex with tripeptidic epoxyketone inhibitor 9 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×MES; 2×38X; | |||
| yCP beta5-A49V mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with epoxyketone inhibitor 16 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×79P; 2×MES; | |||
| yCP beta5-M45A mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 29 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GTW; 2×SO4; | |||
| yCP beta5-A50V mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 6×04C; 2×MES; | |||
| yCP beta5-A49S-mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome beta2-G45A mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 1×MES; 1×SO4; | |||
| yCP beta5-A49T-A50V-double mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 2×MES; | |||
| yCP beta5-C52F mutant in complex with Omuralide |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 5×CL; 6×SLA; | |||
| Yeast 20S proteasome beta2-G170A mutant in complex with Bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome in complex with 39 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 4×GT8; 4×MES; | |||
| yCP beta5-A49V mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome in complex with 4 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 4×GQH; | |||
| Yeast 20S proteasome beta7-delta7_Cter mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; | |||
| yCP in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S proteasome beta2-G45A mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×BO2; | |||
| yCP beta5-M45A mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 2×CL; 6×04C; 4×MES; | |||
| Yeast 20S proteasome beta2-G170A mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; | |||
| yCP in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome in complex with 41b |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 4×GWK; 4×MES; | |||
| Yeast 20S proteasome beta5-T1S mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×MES; | |||
| Yeast 20S proteasome beta5-H(-2)L-T1A double mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 5×CL; 4×3BV; 2×MES; | |||
| Yeast 20S proteasome beta1-T1A mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 4×3BV; 4×MES; | |||
| yCP beta5-A49T-mutant in complex with ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 6×04C; 2×MES; | |||
| Yeast 20S proteasome in complex with 7 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×GQQ; | |||
| Yeast 20S proteasome in complex with 43 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 10×MG; 2×CL; 3×MES; 2×GVW; | |||
| Yeast 20S proteasome in complex with glidobactin-like natural product HB334 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×QOB; | |||
| Yeast 20S proteasome beta5-K33A mutant (propeptide expressed in trans) in complex with MG132 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×ALD; | |||
| Yeast 20S proteasome in complex with Ac-PAY-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome in complex with Ac-LAY-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome beta7-delta7_Cter mutant in complex with Ac-PAL-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 2×MES; | |||
| Yeast 20S proteasome in complex with a linear oxindole epoxyketone (compound 6) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome in complex with Ac-LAD-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×MES; 1×CL; | |||
| Yeast 20S proteasome beta2-H116E mutant in complex with Ac-PAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; | |||
| Yeast 20S proteasome beta2-H116E mutant in complex with Ac-LAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 4×MES; | |||
| Yeast 20S proteasome in complex with the dimerized linear mimetic of TMC-95A - yCP:4e |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×MES; | |||
| yeast 20S proteasome in complex with the Syringolin-Glidobactin chimera |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | ||||
| Yeast 20S proteasome in complex with Ac-PAE-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; | |||
| 20S yeast proteasome in complex with cepafungin I |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | ||||
| Yeast 20S proteasome in complex with Ac-PAF-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 2×MES; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (99-132) in complex with epoxyketone… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 2×CL; 4×MES; 2×6N5; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 12×MG; 4×CL; 4×MES; 2×79P; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×79L; 3×MES; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ep… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 4×6N5; 2×MES; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with bo… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ON… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×04C; 3×MES; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 4×CL; 12×MG; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 4×79L; 2×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×6NV; 1×MES; | |||
| TMC-95 based biphenyl-ether macrocycles: specific proteasome inhibitors |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×BIQ; | |||
| Crystal structure of yeast 20S proteasome in complex with the epimer form of spirolactacystin |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×SLR; | |||
| Structure of yeast 20S open-gate proteasome with Compound 25 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; 2×3OE; 2×MES; | |||
| Yeast 20S proteasome in complex with the vinyl sulfone LU122 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×1G5; | |||
| yeast 20S proteasome:syringolin A-complex |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×SRG; | |||
| Yeast 20S proteasome beta2-H116N mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 4×CL; 9×MG; | |||
| yCP in complex with tripeptidic epoxyketone inhibitor 17 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×MES; 2×39Q; | |||
| Yeast 20S proteasome beta1-T1A beta2-T1A double mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 4×CL; 2×3BV; 2×MES; | |||
| Yeast 20S proteasome beta5-D17N mutant in complex with Carfilzomib; Propeptide expressed in trans |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S Proteasome in complex with Homosalinosporamide A |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×F6K; | |||
| Yeast 20S proteasome in complex with glidobactin-like natural product HB333 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×QOH; | |||
| yCP in complex with Z-Leu-Leu-Leu-epoxyketone |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 3×2L0; 1×2LR; | |||
| yCP beta5-A50V mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 16 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GRW; 2×SO4; | |||
| yCP beta5-M45V mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 4×CL; 6×3BV; 4×MES; | |||
| yCP beta5-A49T-A50V double mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×04C; 2×MES; | |||
| Yeast 20S proteasome beta2-H114D mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with epoxyketone inhibitor 18 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 3×CL; 2×MES; 2×6NV; | |||
| yCP beta5-C63F mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 5×MG; 4×CL; 6×BO2; | |||
| yCP beta5-M45V mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×BO2; | |||
| Yeast 20S proteasome beta5-T1C mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 4×3BV; 2×MES; | |||
| yCP beta5-C52F mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; | |||
| yCP in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×04C; 4×MES; 2×NA; | |||
| Yeast 20S proteasome beta5-T1S mutant in complex with Carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 4×MES; | |||
| Yeast 20S proteasome in complex with 16 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×GRW; | |||
| yCP beta5-A49T-mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 2×MES; | |||
| yCP beta5-C52F mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×3BV; 2×MES; | |||
| Ligand-induced Lys33-Thr1 crosslinking at the yeast proteasomal subunit beta5 by sulfonate esters |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; | |||
| Yeast 20S proteasome in complex with 18 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×GRT; | |||
| yCP beta5-A49T-A50V-double mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×BO2; | |||
| yCP in complex with Omuralide |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×SLA; | |||
| Yeast 20S proteasome in complex with the peptidic epoxyketone inhibitor 27 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 3×CL; 2×6KF; 2×MES; | |||
| Yeast 20S proteasome in complex with Ac-PAD-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with the dimerized linear mimetic of TMC-95A - yCP:3a |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×MES; | |||
| Yeast 20S proteasome beta5-G48C mutant in complex with alpha-chloroacetamide 1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 2×MES; | |||
| Yeast 20S proteasome beta2-H116D mutant in complex with Ac-PAD-ep |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 1×CL; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 29 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GTW; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 2×38X; 2×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138;V31M) and human beta6 (97-111; 118-133) |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome with human beta5i (1-138; V31M) and human beta6 (97-111; 118-133) in complex w… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 1×MES; 2×79P; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 20 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GT5; | |||
| Yeast 20S proteasome with mouse beta5i (1-138) and mouse beta6 (97-111; 118-133) in complex with ca… |
Heteromer O09061; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28063; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 2×MES; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 13 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GQT; | |||
| Yeast 20S proteasome with human beta5c (1-138) and human beta6 (97-111; 118-133) in complex with ON… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28074; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; 2×CL; 6×04C; 4×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ep… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×6N5; 2×MES; | |||
| Yeast 20S proteasome with human beta5i (1-138) and human beta6 (97-111; 118-133) in complex with ca… |
Heteromer P20618; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P28062; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 2×MES; | |||
| Yeast 20S proteasome in complex with a photoswitchable cepafungin derivative (transCep4) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; 4×VOX; 2×CL; 2×SO4; | |||
| Crystal Structure of the Yeast 20S Proteasome in Complex with Homobelactosin C |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×ESY; | |||
| yCP beta5-A49S mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 6×04C; 2×MES; | |||
| Yeast 20S proteasome in complex with the peptidic epoxyketone inhibitor 15 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; 3×6KG; 4×MES; | |||
| Yeast 20S proteasome in complex with glidobactin-like natural product HB335 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×QOE; | |||
| yCP beta5-M45T mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 2×CL; 6×04C; 4×MES; 3×MG; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 20 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GT5; 2×SO4; | |||
| yCP beta5-C52F mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×BO2; | |||
| yCP beta5-C63F mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 4×CL; 6×3BV; 4×MES; 4×MG; | |||
| yCP beta5-A49S-mutant in complex with bortezomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×BO2; | |||
| yCP in complex with Z-Leu-Leu-Leu-vinylsulfone |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×2M1; | |||
| yCP beta5-M45V mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 2×CL; | |||
| yCP beta5-C52F mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 4×04C; 2×MES; | |||
| yCP beta5-A49T-mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 9×MG; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 4 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GQH; 2×SO4; | |||
| Yeast 20S proteasome in complex with belactosin C derivative 3 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×CL; 6×4KF; | |||
| Yeast 20S proteasome in complex with the covalently bound inhibitor b-lactone (2R,3S)-3-isopropyl-4… |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×V08; | |||
| Yeast 20S proteasome in complex with Cystargolide B Derivative 2 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 6×EQB; | |||
| yCP beta5-M45A mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 5×MG; 4×CL; 6×3BV; 4×MES; | |||
| yCP beta5-M45V mutant in complex with the epoxyketone inhibitor ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 2×CL; 6×04C; 4×MES; | |||
| yCP beta5-M45I mutant in complex with carfilzomib |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 7×MG; 4×CL; 6×3BV; 4×MES; | |||
| Crystal Structure of the yeast 20S Proteasome:TMC-95A complex: A non-covalent Proteasome Inhibitor |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; | |||
| yCP in complex with BOC-ALA-ALA-ALA-CHO |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 11×MG; | |||
| 20S yeast proteasome in complex with glidobactin |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | ||||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 18 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GRT; 2×SO4; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 7 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GQQ; 2×SO4; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 43 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GVW; 6×MES; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with ONX 0914 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 6×GQK; 4×MES; 2×SO4; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 4 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GQH; | |||
| Yeast 20S proteasome in complex with a macrocyclic oxindole epoxyketone (compound 5) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with the vinyl sulfone LU112 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 4×1G6; | |||
| Yeast 20S proteasome with human beta2c (S171G) in complex with 39 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25451; P30656; P30657; P38624; P40302; P40303; Q99436; | 100.0 | 8×MG; 2×CL; 4×GT8; 6×MES; 2×SO4; | |||
| yCP beta5-A49T-A50V-double mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 6×MG; 2×CL; | |||
| Yeast 20S proteasome in complex with the dimerized linear mimetic of TMC-95A - yCP:4a |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 2×MES; 1×0L1; | |||
| Yeast 20S proteasome in complex with a sybactin derivative (PheSyr) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 4×A1H71; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 18 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GRT; | |||
| Structure of yeast 20S proteasome with Compound 1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 10×MG; 2×LXT; 2×MES; | |||
| Yeast 20S proteasome with a mutation of alpha7 subunit |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Yeast 20S proteasome in complex with a linear biarylether epoxyketone (compound 15a) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 2×CL; 1×MES; | |||
| Yeast 20S proteasome in complex with an engineered fellutamide derivative (C14QAL) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 8×MG; 3×CL; 4×MYR; | |||
| Yeast 20S proteasome in complex with PR-957 (morpholine) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 6×04C; | |||
| Yeast 20S proteasome with human beta2i (1-53) in complex with 7 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P40306; | 100.0 | 8×MG; 2×CL; 4×GQQ; | |||
| Structure of yeast 26S proteasome in M1 state derived from Titan dataset |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| 26S proteasome in presence of BeFx (s4) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P43593; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 4×ATP; 6×MG; 2×ADP; | |||
| Structure of yeast 26S proteasome in M2 state derived from Titan dataset |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| 26S proteasome in presence of ATP (s1) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P33297; P33298; P33299; P38624; P40302; P40303; P40327; P53549; Q01939; | 100 | 5×ATP; 6×MG; 1×ADP; | |||
| 26S proteasome in presence of ATP (s2) |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P33297; P33298; P33299; P38624; P40302; P40303; P40327; P53549; Q01939; | 100 | 6×MG; 5×ATP; 1×ADP; | |||
| Yeast proteasome-ADP-AlFx |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| yeast proteasome in Ub-engaged state (C2) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Yeast proteasome in resting state (C1-a) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| yeast proteasome in substrate-processing state (C3-b) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Cryo-EM structure of the Pre3-1 20S proteasome core particle |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Yeast proteasome in Ub-accepted state (C1-b) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Yeast proteasome in translocation competent state (C3-a) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | ||||
| Yeast 26S proteasome bound to ubiquitinated substrate (5D motor state) |
Heteromer P07818; P21242; P21243; P23638; P23639; P33297; P33298; P33299; P40302; P40303; P40327; P53549; Q01939; | 100 | 4×ATP; 2×ADP; | |||
| 26S proteasome in presence of AMP-PNP (s3) |
Heteromer O13563; O94742; P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P32496; P32565; P33297; P33298; P33299; P38624; P38764; P38886; P40016; P40302; P40303; P40327; P43588; P53549; Q01939; Q04062; Q06103; Q08723; Q12250; Q12377; | 100 | 5×ANP; 6×MG; 1×ADP; | |||
| Blm10-20S proteasome complex from pre1-1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; P43583; | 100.0 | ||||
| A GATED CHANNEL INTO THE PROTEASOME CORE PARTICLE |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100 | 20×MG; | |||
| Structure of yeast 20S open-gate proteasome with Compound 20 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | 20×MG; 2×3SD; 2×MES; | |||
| 20S proteasome from pre1-1 |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Cryo-EM structure of the 20S Alpha 3 Deletion proteasome core particle in complex with FUB1 |
Heteromer P21242; P21243; P22141; P23639; P23724; P25043; P25451; P25659; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Proteasome 20S core particle from Pre1-1 Pre4-1 Double mutant |
Heteromer P21242; P21243; P22141; P23638; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Cryo-EM structure of the 20S Alpha 3 Deletion proteasome core particle |
Heteromer P21242; P21243; P22141; P23639; P23724; P25043; P25451; P30656; P30657; P38624; P40302; P40303; | 100.0 | ||||
| Crystal Structure of a Novel Chaperone Complex for Yeast 20S Proteasome Assembly |
Heteromer Q07951; Q12245; | 100.0 | ||||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 7ls5.1.S | monomer | 0.82 | 100.00 | |||